Copper, iron and zinc in Alzheimer's disease senile plaques

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported

Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,627

Rapid induction of Alzheimer A beta amyloid formation by zinc

Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296

Release of endogenous Zn2+ from brain tissue during activity

Assaf, S. Y., & Chung, S. (1984) · Nature · doi:10.1038/308734a0 · Cited by 1,113

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086

Novel 8‐Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer′s Disease

Prati, F., Bergamini, C., Fato, R., Soukup, O., Korábečný, J., Andrisano, V., Bartolini, M., & Bolognesi, M. L. (2016) · ChemMedChem · doi:10.1002/cmdc.201600014 · Cited by 91

Aluminum and other metals in Alzheimer's disease: A review of potential therapy with chelating agents

Domingo, J. L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-102-315 · Cited by 91

Manganese modulates pro-inflammatory gene expression in activated glia

Chen, C., Ou, Y., Lin, S., Liao, S., Chen, S., & Chen, J. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.020 · Cited by 91

Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic

Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 93

Characterization of copper binding to the peptide amyloid‐β(1–16) associated with Alzheimer's disease

Ma, Q., Hu, J. N., Wu, W., Liu, H., Du, J., Fu, Y., Wu, Y., Lei, P., Zhao, Y., & Li, Y. (2006) · Biopolymers · doi:10.1002/bip.20523 · Cited by 91

Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production

Gerber, H., Wu, F., Dimitrov, M. I., Osuna, G. M. G., & Fraering, P. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754101 · Cited by 89

Zinc and Central Nervous System Disorders

Wang, B., Fang, T., & Chen, H. (2023) · Nutrients · doi:10.3390/nu15092140 · Cited by 93

Copper Transfer from Cu–Aβ to Human Serum Albumin Inhibits Aggregation, Radical Production and Reduces Aβ Toxicity

Perrone, L., Mothes-Martin, E., Vignes, M., Mockel, A., Figueroa, C. M., Miquel, M., Maddelein, M., & Faller, P. (2009) · ChemBioChem · doi:10.1002/cbic.200900474 · Cited by 93

Somatostatin and Alzheimer's disease

Burgos‐Ramos, E., Hervás‐Aguilar, A., Aguado‐Llera, D., Puebla‐Jiménez, L., Hernández‐Pinto, A. M., Barrios, V., & Arilla, E. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.014 · Cited by 88

‘Free’ copper in serum of Alzheimer’s disease patients correlates with markers of liver function

Squitti, R., Ventriglia, M., Barbati, G., Cassetta, E., Ferreri, F., Forno, G. D., Ramires, S., Zappasodi, F., & Rossini, P. M. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0777-6 · Cited by 89

Inhibitory Effect of Copper(II) on Zinc(II)-Induced Aggregation of Amyloid β-Peptide

Suzuki, K., Miura, T., & Takeuchi, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5263 · Cited by 90

Exacerbation of Copper Toxicity in Primary Neuronal Cultures Depleted of Cellular Glutathione

White, A. R., Bush, A. I., Beyreuther, K. T., Masters, C. L., & Cappai, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722092.x · Cited by 89

Review: Iron metabolism and the role of iron in neurodegenerative disorders

Hadzhieva, M., Kirches, E., & Mawrin, C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12096 · Cited by 90

Development of Bifunctional Stilbene Derivatives for Targeting and Modulating Metal-Amyloid-β Species

Braymer, J. J., Choi, J.-S., DeToma, A. S., Wang, C., Nam, K., Kampf, J. W., Ramamoorthy, A., & Lim, M. H. (2011) · Inorganic Chemistry · doi:10.1021/ic2012205 · Cited by 89

Multifunctional carbon dots as a therapeutic nanoagent for modulating Cu( ii )-mediated β-amyloid aggregation

Chung, Y. J., Lee, B. I., & Park, C. B. (2019) · Nanoscale · doi:10.1039/c9nr00473d · Cited by 88

Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease

Birla, H., Minocha, T., Kumar, G., Misra, A., & Singh, S. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200122122512 · Cited by 90

Trace Copper(II) or Zinc(II) Ions Drastically Modify the Aggregation Behavior of Amyloid-β1–42: An AFM Study

Innocenti, M., Salvietti, E., Guidotti, M., Casini, A., Bellandi, S., Foresti, M. L., Gabbiani, C., Pozzi, A., Zatta, P. F., & Luigi Messori, A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1338 · Cited by 87

Mechanism of copper(II)-induced misfolding of Parkinson's disease protein

Rose, F., Hodak, M., & Bernholc, J. (2011) · Scientific Reports · doi:10.1038/srep00011 · Cited by 88

Zinc Overload Enhances APP Cleavage and Aβ Deposition in the Alzheimer Mouse Brain

Wang, C., Wang, T., Zheng, W., Zhao, B., Danscher, G., Chen, Y., & Wang, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015349 · Cited by 93

Iron and Brain Disorders

Sadrzadeh, S. M. H., & Saffari, Y. (2004) · Pathology Patterns Reviews · doi:10.1309/ew0121lg9n3n1yl4 · Cited by 88

The missing link in the amyloid cascade of Alzheimer’s disease – Metal ions

Tiiman, A., Palumaa, P., & Tõugu, V. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.023 · Cited by 92

Restored degradation of the Alzheimer’s amyloid‐β peptide by targeting amyloid formation

Crouch, P. J., Tew, D. J., Du, T., Nguyen, D., Caragounis, A., Filiz, G., Blake, R. E., Trounce, I. A., Soon, C. P. W., Laughton, K. M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05870.x · Cited by 88

Alzheimer’s Disease: A Heme–Aβ Perspective

Ghosh, C., Seal, M., Mukherjee, S., & Dey, S. G. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00102 · Cited by 89

A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease

Lovell, M. A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0992 · Cited by 87

Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer’s Disease

Portbury, S. D., Hare, D. J., Sgambelloni, C., Perronnes, K., Portbury, A. J., Finkelstein, D. I., & Adlard, P. A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170322 · Cited by 87

Zinc Chloride Exposure Inhibits Brain Acetylcholine Levels, Produces Neurotoxic Signatures, and Diminishes Memory and Motor Activities in Adult Zebrafish

Sarasamma, S., Audira, G., Juniardi, S., Sampurna, B. P., Liang, S., Hao, E., Lai, Y., & Hsiao, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103195 · Cited by 89

Intracellular copper deficiency increases amyloid-β secretion by diverse mechanisms

Cater, M. A., McInnes, K. T., Li, Q., Volitakis, I., Fontaine, S. L., Mercer, J. F. B., & Bush, A. I. (2008) · Biochemical Journal · doi:10.1042/bj20080103 · Cited by 87

A review of genome mutation and Alzheimer's disease

Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 88

Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations

Uchida, Y., Kan, H., Sakurai, K., Oishi, K., & Matsukawa, N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.938092 · Cited by 88

The potential application of iron chelators for the treatment of neurodegenerative diseases

Hider, R. C., Roy, S., Ma, Y. M., Kong, X. L., & Preston, J. E. (2011) · Metallomics · doi:10.1039/c0mt00087f · Cited by 86

The Novel Multi-Target Iron Chelating-Radical Scavenging Compound M30 Possesses Beneficial Effects on Major Hallmarks of Alzheimer's Disease

Kupershmidt, L., Amit, T., Bar‐Am, O., Youdim, M. B. H., & Weinreb, O. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4279 · Cited by 85

Copper and iron in Alzheimer's disease: a systematic review and its dietary implications

Loef, M., & Walach, H. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100376x · Cited by 87

Chelation and Intercalation: Complementary Properties in a Compound for the Treatment of Alzheimer's Disease

Cherny, R. A., Barnham, K. J., Lynch, T., Volitakis, I., Li, Q.-X., McLean, C., Multhaup, G., Beyreuther, K. T., Tanzi, R. E., Masters, C. L., et al. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4285 · Cited by 85

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease

Khan, N. H., Mir, M., Ngowi, E. E., Zafar, U., Khakwani, M. M. A. K., Khattak, S., Zhai, Y., Jiang, E., Zheng, M., Duan, S., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.630055 · Cited by 84

The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology

Fanlo-Ucar, H., Picón-Pagès, P., Herrera-Fernández, V., ILL‐Raga, G., & Muñoz, F. J. (2024) · Antioxidants · doi:10.3390/antiox13101208 · Cited by 94

Zinc-mediated Allosteric Inhibition of Caspase-6

Velázquez-Delgado, E. M., & Hardy, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397752 · Cited by 84

Modulation of tau phosphorylation by environmental copper

Voss, K., Harris, C., Ralle, M., Duffy, M., Murchison, C., & Quinn, J. F. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-24 · Cited by 83

Exposure of metal toxicity in Alzheimer’s disease: An extensive review

Islam, F., Shohag, S., Akhter, S., Islam, M. R., Sultana, S., Mitra, S., Chandran, D., Khandaker, M. U., Ashraf, G. M., Idris, A. M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.903099 · Cited by 83

Copper Imbalance in Alzheimer’s Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants

Squitti, R., Ventriglia, M., Simonelli, I., Bonvicini, C., Costa, A. C., Perini, G., Binetti, G. G., Benussi, L., Ghidoni, R., Koch, G., et al. (2021) · Biomolecules · doi:10.3390/biom11070960 · Cited by 84

Bis (thiosemicarbazonato) Cu-64 Complexes for Positron Emission Tomography Imaging of Alzheimer's Disease

Fodero‐Tavoletti, M. T., Villemagne, V. L., Paterson, B. M., White, A. R., Li, Q., Camakaris, J., O'Keefe, G. J., Cappai, R., Barnham, K. J., & Donnelly, P. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1359 · Cited by 83

The effect of formalin fixation on the levels of brain transition metals in archived samples

Schrag, M., Dickson, A., Jiffry, A., Kirsch, D., Vinters, H. V., & Kirsch, W. M. (2010) · BioMetals · doi:10.1007/s10534-010-9359-4 · Cited by 83

Direct Evidence That All Three Histidine Residues Coordinate to Cu(II) in Amyloid-β1−16

Shin, B., & Saxena, S. (2008) · Biochemistry · doi:10.1021/bi801014x · Cited by 83

Reaction Rates and Mechanism of the Ascorbic Acid Oxidation by Molecular Oxygen Facilitated by Cu(II)-Containing Amyloid-β Complexes and Aggregates

Jiang, D., Li, X., Liu, L., Yagnik, G. B., & Zhou, F. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp9095375 · Cited by 83

Role of glycine-33 and methionine-35 in Alzheimer’s amyloid β-peptide 1–42-associated oxidative stress and neurotoxicity

Kański, J., Varadarajan, S., Aksenova, M. V., & Butterfield, D. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00097-7 · Cited by 83

Free Copper Distinguishes Mild Cognitive Impairment Subjects from Healthy Elderly Individuals

Squitti, R., Ghidoni, R., Scrascia, F., Benussi, L., Panetta, V., Pasqualetti, P., Moffa, F., Bernardini, S., Ventriglia, M., Binetti, G. G., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101098 · Cited by 82

Potential pathogenic role of β-amyloid1–42–aluminum complex in Alzheimer's disease

Drago, D., Bettella, M., Bolognin, S., Cendron, L., Ščančar, J., Milačić, R., Ricchelli, F., Casini, A., Luigi Messori, A., Tognon, G., et al. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.014 · Cited by 82

Contrasting, Species-Dependent Modulation of Copper-Mediated Neurotoxicity by the Alzheimer's Disease Amyloid Precursor Protein

White, A. R., Multhaup, G., Galatis, D., McKinstry, W. J., Parker, M. W., Pipkorn, R., Beyreuther, K. T., Masters, C. L., & Cappai, R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00365.2002 · Cited by 82

Gold Nanocage‐Based Dual Responsive “Caged Metal Chelator” Release System: Noninvasive Remote Control with Near Infrared for Potential Treatment of Alzheimer's Disease

Shi, P., Li, M., Ren, J., & Qu, X. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201301015 · Cited by 82

Metal-catalyzed oxidation of Aβ and the resulting reorganization of Cu binding sites promote ROS production

Cheignon, C., Faller, P., Testemale, D., Hureau, C., & Collin, F. (2016) · Metallomics · doi:10.1039/c6mt00150e · Cited by 81

The role of iron as a mediator of oxidative stress in Alzheimer disease

Castellani, R. J., Moreira, P. I., Perry, G. L., & Zhu, X. (2012) · BioFactors · doi:10.1002/biof.1010 · Cited by 82

Amyloid-β and α-Synuclein Decrease the Level of Metal-Catalyzed Reactive Oxygen Species by Radical Scavenging and Redox Silencing

Pedersen, J. T., Chen, S. W., Borg, C. B., Ness, S., Bahl, J. M. C., Heegaard, N. H. H., Dobson, C. M., Hemmingsen, L., Cremades, N., & Teilum, K. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b13577 · Cited by 81

The Role of Microglia in Sporadic Alzheimer’s Disease

Streit, W. J., Khoshbouei, H., & Bechmann, I. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201248 · Cited by 87

Copper reduction by copper binding proteins and its relation to neurodegenerative diseases

Opazo, C., Barría, M. I., Ruiz, F. H., & Inestrosa, N. C. (2003) · BioMetals · doi:10.1023/a:1020795422185 · Cited by 83

A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease

Palanimuthu, D., Poon, R., Sahni, S., Anjum, R., Hibbs, D. E., Lin, H.-Y. J., Bernhardt, P. V., Kalinowski, D. S., & Richardson, D. R. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.021 · Cited by 82

β‐Amyloid aggregation and heterogeneous nucleation

Srivastava, A. K., Pittman, J. M., Zerweck, J., Venkata, B. S., Moore, P. C., Sachleben, J. R., & Meredith, S. C. (2019) · Protein Science · doi:10.1002/pro.3674 · Cited by 82

Multifunctional roles of zinc in Alzheimer’s disease

Xie, Z., Wu, H., & Zhao, J. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.07.003 · Cited by 94

Single Cell Transcriptomics of Ependymal Cells Across Age, Region and Species Reveals Cilia-Related and Metal Ion Regulatory Roles as Major Conserved Ependymal Cell Functions

MacDonald, A., Lu, B., Caron, M., Caporicci‐Dinucci, N., Hatrock, D. J., Petrecca, K., Bourque, G., & Stratton, J. A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.703951 · Cited by 85

Effect of Cerebral Amyloid Angiopathy on Brain Iron, Copper, and Zinc in Alzheimer's Disease

Schrag, M., Crofton, A. R., Zabel, M. K., Jiffry, A., Kirsch, D., Dickson, A., Mao, X. W., Vinters, H. V., Domaille, D. W., Chang, C. J., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101503 · Cited by 80

Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities

Weinreb, O., Amit, T., Mandel, S. A., Kupershmidt, L., & Youdim, M. B. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2929 · Cited by 80

New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc

Corona, C., Pensalfini, A., Frazzini, V., & Sensi, S. L. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.57 · Cited by 81

Amyloidosis of Alzheimer's Aβ peptides: solid‐state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies

Antzutkin, O. N. (2004) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.1341 · Cited by 80

Metals in alzheimer's disease: a systemic perspective

Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 80

Copper(II) Coordination to Amyloid β: Murine versus Human Peptide

Eury, H., Bijani, C., Faller, P., & Hureau, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201005838 · Cited by 79

A doença de Alzheimer: aspectos fisiopatológicos e farmacológicos

Sereniki, A., & Vital, M. A. B. F. (2008) · Revista de Psiquiatria do Rio Grande do Sul · doi:10.1590/s0101-81082008000200002 · Cited by 121

Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease

Kessler, H., Pajonk, F., Meisser, P., Schneider-Axmann, T., Hoffmann, K.-H., Supprian, T., Herrmann, W., Obeid, R., Multhaup, G., Falkai, P., et al. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0485-7 · Cited by 81

Selective Cu2+ Binding, Redox Silencing, and Cytoprotective Effects of the Small Heat Shock Proteins αA- and αB-Crystallin

Ahmad, M. F., Singh, D., Taiyab, A., Ramakrishna, T., Raman, B., & Rao, C. M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.068 · Cited by 78

Subneurotoxic copper(II)-induced NF-κB-dependent microglial activation is associated with mitochondrial ROS

Hu, Z., Yu, F., Gong, P., Qiu, Y. L., Zhou, W., Cui, Y., Li, J., & Chen, H. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.01.020 · Cited by 79

Affinity of Cu+ for the Copper-Binding Domain of the Amyloid-β Peptide of Alzheimer’s Disease

Feaga, H. A., Maduka, R. C., Foster, M. N., & Szalai, V. A. (2011) · Inorganic Chemistry · doi:10.1021/ic100967s · Cited by 77

Re‐evaluation of the existing health‐based guidance values for copper and exposure assessment from all sources

More, S. J., Bampidis, V., Benford, D., Bragard, C., Halldorsson, T. I., Hernández, A. F., Bennekou, S. H., Koutsoumanis, K., Lambré, C., Machera, K. A., et al. (2023) · EFSA Journal · doi:10.2903/j.efsa.2023.7728 · Cited by 99

Transition metal abnormalities in progressive dementias

Akatsu, H., Hori, A., Yamamoto, T., Yoshida, M., Mimuro, M., Hashizume, Y., Tooyama, I., & Yezdimer, E. M. (2011) · BioMetals · doi:10.1007/s10534-011-9504-8 · Cited by 78

Cu(II) interaction with N-terminal fragments of human and mouse β-amyloid peptide

Kowalik‐Jankowska, T. (2001) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00226-4 · Cited by 78

Pathological BBB Crossing Melanin-Like Nanoparticles as Metal-Ion Chelators and Neuroinflammation Regulators against Alzheimer’s Disease

Huang, Q., Jiang, C., Xia, X., Wang, Y., Yan, C., Wang, X., Lei, T., Yang, X., Yang, W., Cheng, G., et al. (2023) · Research · doi:10.34133/research.0180 · Cited by 78

Oxidative Genome Damage and its Repair in Neurodegenerative Diseases: Function of Transition Metals as a Double-Edged Sword

Hegde, M. L., Hegde, P. M., Rao, K. S. J., & MITRA, S. P. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110281 · Cited by 78

Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold

Grabrucker, A. M., Schmeißer, M. J., Udvardi, P. T., Arons, M. H., Schoen, M., Woodling, N. S., Andreasson, K. I., Hof, P. R., Buxbaum, J. D., Garner, C. C., et al. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-65 · Cited by 77

Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias

Magaki, S., Raghavan, R., Mueller, C., Oberg, K. C., Vinters, H. V., & Kirsch, W. M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.077 · Cited by 77

The modulation of metal bio‐availability as a therapeutic strategy for the treatment of Alzheimer's disease

Crouch, P. J., White, A. R., & Bush, A. I. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05918.x · Cited by 78

Towards a Unified Vision of Copper Involvement in Alzheimer's Disease: A Review Connecting Basic, Experimental, and Clinical Research

Pal, A., Siotto, M., Prasad, R., & Squitti, R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141194 · Cited by 76

Biphasic effects of copper on neurotransmission in rat hippocampal neurons

Peters, C., Muñoz, B., Sepúlveda, F. J., Urrutia, J. C., Quiroz, M., Luza, S., Ferrari, G. V. D., Aguayo, L. G., & Opazo, C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07417.x · Cited by 78

Radioiodinated clioquinol as a biomarker for β‐amyloid: Zn2+ complexes in Alzheimer's disease

Opazo, C., Luza, S., Villemagne, V. L., Volitakis, I., Rowe, C. C., Barnham, K. J., Altschul, D., Masters, C. L., Cherny, R. A., & Bush, A. I. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00196.x · Cited by 76

Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron

Hegde, M. L., Hegde, P. M., Holthauzen, L. M. F., Hazra, T. K., Rao, K. S. J., & MITRA, S. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126664 · Cited by 76

Neuroferritinopathy: A Window on the Role of Iron in Neurodegeneration

Crompton, D. E., Chinnery, P. F., Fey, C., Curtis, A. R. J., Morris, C. M., Kierstan, J., Burt, A. D., Young, F., Coulthard, A., Curtis, A., et al. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0589 · Cited by 76

Nutritional and Phyto-Therapeutic Potential of Papaya (Carica Papaya Linn.): An Overview

Saeed, F., Arshad, M. U., Pasha, I., Naz, R., Batool, R., Khan, A. A., Nasir, M. A., & Shafique, B. (2013) · International Journal of Food Properties · doi:10.1080/10942912.2012.709210 · Cited by 81

Amyloidosis in Alzheimer’s Disease: The Toxicity of Amyloid Beta (Aβ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy

Prasansuklab, A., & Tencomnao, T. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/413808 · Cited by 77

Rapid Formation of a Preoligomeric Peptide–Metal–Peptide Complex Following Copper(II) Binding to Amyloid β Peptides

Pedersen, J. T., Teilum, K., Heegaard, N. H. H., Østergaard, J., Adolph, H., & Hemmingsen, L. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006335 · Cited by 75

Aluminum Modulates Effects of β Amyloid 1–42 on Neuronal Calcium Homeostasis and Mitochondria Functioning and Is Altered in a Triple Transgenic Mouse Model of Alzheimer's Disease

Drago, D., Cavaliere, A., Mascetra, N., Ciavardelli, D., Ilio, C. D., Zatta, P. F., & Sensi, S. L. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0761 · Cited by 74

The Chemistry of Neurodegeneration: Kinetic Data and Their Implications

Pavlin, M., Repič, M., Vianello, R., & Mavri, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9284-1 · Cited by 75

Copper(II) interaction with amyloid-β: Affinity and speciation

Arena, G., Pappalardo, G., Sóvágó, I., & Rizzarelli, E. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.07.012 · Cited by 74

Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives

La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74

Quantification of the Binding Properties of Cu2+ to the Amyloid Beta Peptide: Coordination Spheres for Human and Rat Peptides and Implication on Cu2+-Induced Aggregation

Hong, L., Carducci, T. M., Bush, W. D., Dudzik, C. G., Millhauser, G. L., & Simon, J. D. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp103272v · Cited by 73

Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease

Hao, Q., & Maret, W. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8209 · Cited by 74

Elucidating the Interaction of Human Ferritin with Quercetin and Naringenin: Implication of Natural Products in Neurodegenerative Diseases: Molecular Docking and Dynamics Simulation Insight

Shamsi, A., Shahwan, M. J., Khan, M. S., Husain, F. M., Alhumaydhi, F. A., Aljohani, A. S. M., Rehman, M. T., Hassan, M. I., & Islam, A. (2021) · ACS Omega · doi:10.1021/acsomega.1c00527 · Cited by 76

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Vitalakumar, D., Sharma, A., & Flora, S. J. S. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22830 · Cited by 75

Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding

Grant, W. B., & Blake, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230418 · Cited by 82

Resveratrol Acts Not through Anti-Aggregative Pathways but Mainly via Its Scavenging Properties against Aβ and Aβ-Metal Complexes Toxicity

Granzotto, A., & Zatta, P. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021565 · Cited by 74

Hohenheim Consensus Workshop: Copper

Schümann, K., Classen, H.-G., Dieter, H. H., König, J. S., Multhaup, G., Rükgauer, M., Summer, K., Bernhardt, J., & Biesalski, H.-K. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601315 · Cited by 71

Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies

Martinelli, A. H. S., Lopes, F. C., John, E. B. D. O., Carlini, C. R., & Ligabue‐Braun, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061322 · Cited by 99

The Synucleins Are a Family of Redox-Active Copper Binding Proteins

Davies, P., Wang, X., Sarell, C. J., Drewett, A., Marken, F., Viles, J. H., & Brown, D. R. (2010) · Biochemistry · doi:10.1021/bi101582p · Cited by 72

Brain proteins that mind metals: a neurodegenerative perspective

Brown, D. R. (2009) · Dalton Transactions · doi:10.1039/b822135a · Cited by 72

Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition

Yoo, J., Lee, J., Ahn, B., Han, J., & Lim, M. H. (2025) · Chemical Science · doi:10.1039/d4sc06762b · Cited by 78

Analytical methods for copper, zinc and iron quantification in mammalian cells

Cerchiaro, G., Manieri, T. M., & Bertuchi, F. R. (2013) · Metallomics · doi:10.1039/c3mt00136a · Cited by 73

Zinc and Alzheimer's Disease: An Update

Cuajungco, M. P., Lees, G. J., Kydd, R. R., Tanzi, R. E., & Bush, A. I. (1999) · Nutritional Neuroscience · doi:10.1080/1028415x.1999.11747277 · Cited by 6

Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer’s Disease Correlates with Metal Levels in the Surrounding Neuropil

James, S., Churches, Q. I., de Jonge, M. D., Birchall, I. E., Streltsov, V. A., McColl, G., Adlard, P. A., & Hare, D. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00362 · Cited by 136

Elevated cortical zinc in Alzheimer disease

Religa, D., Strozyk, D., Cherny, R. A., Volitakis, I., Haroutunian, V., Winblad, B. G., Näslund, J., & Bush, A. I. (2006) · Neurology · doi:10.1212/01.wnl.0000223644.08653.b5 · Cited by 273

Association of trace elements Aluminum, Copper and Zinc in blood of Alzheimer's disease

Anwar, M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70860_107018

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress.

Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540